| PRECLINICAL | evidence | Multi working mode SPR chip laboratory for high refractive index detection. | GHK-Cu | — | 2023-06-19 |
| PRECLINICAL | evidence | Glycyl-l-histidyl-l-lysine-Cu(2+) rescues cigarette smoking-induced skeletal muscle dysfunction via a sirtuin 1-dependent pathway. | Cu-GHK | — | 2023-06-01 |
| PRECLINICAL | evidence | Glycyl-l-histidyl-l-lysine-Cu(2+) rescues cigarette smoking-induced skeletal muscle dysfunction via a sirtuin 1-dependent pathway. | GHK | Muscle growth & preservation | 2023-06-01 |
| PRECLINICAL | evidence | Advanced 3D dynamic culture system with transforming growth factor-beta3 enhances production of potent extracellular vesicles with modified protein cargoes via upregulation of TGF-beta signaling. | GHK | — | 2023-05-01 |
| PRECLINICAL | evidence | Release systems based on self-assembling RADA16-I hydrogels with a signal sequence which improves wound healing processes. | GHK | — | 2023-04-18 |
| PRECLINICAL | evidence | Differential Effects of Histidine and Histidinamide versus Cysteine and Cysteinamide on Copper Ion-Induced Oxidative Stress and Cytotoxicity in HaCaT Keratinocytes. | GHK | — | 2023-03-25 |
| PRECLINICAL | evidence | Differential Effects of Histidine and Histidinamide versus Cysteine and Cysteinamide on Copper Ion-Induced Oxidative Stress and Cytotoxicity in HaCaT Keratinocytes. | GHK-Cu | — | 2023-03-25 |
| PRECLINICAL | evidence | Improved laccase production by Trametes versicolor using Copper-Glycyl-L-Histidyl-L-Lysine as a novel and high-efficient inducer. | GHK-Cu | — | 2023-01-01 |
| PRECLINICAL | evidence | GHK peptide prevents sleep-deprived learning impairment in aging mice. | GHK | — | 2023-01-01 |
| PRECLINICAL | evidence | Improved laccase production by Trametes versicolor using Copper-Glycyl-L-Histidyl-L-Lysine as a novel and high-efficient inducer. | GHK | — | 2023-01-01 |
| PRECLINICAL | evidence | Synthesis and neuroprotective effects of H(2)S-donor-peptide hybrids on hippocampal neuronal cells. | GHK | — | 2023-01-01 |
| PRECLINICAL | evidence | Role of peptide-cell surface interactions in cosmetic peptide application. | GHK | — | 2023-01-01 |
| PRECLINICAL | evidence | [Molecular tandem repeat strategy for production ofultrashort peptides]. | GHK | — | 2022-12-25 |
| PRECLINICAL | evidence | Structural basis for lipid and copper regulation of the ABC transporter MsbA. | GHK | — | 2022-11-26 |
| PRECLINICAL | evidence | Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trials. | GHK | — | 2022-10-01 |
| PRECLINICAL | evidence | Polyaspartic acid, 2-acrylamido-2-Methyl propane sulfonic acid and sodium alginate based biocompatible stimuli responsive polymer gel for controlled release of GHK-Cu peptide for wound healing. | GHK | Wound healing | 2022-07-01 |
| PRECLINICAL | evidence | A novel peptide-based fluorescent probe for highly selective detection of mercury (II) ions in real water samples and living cells based on aggregation-induced emission effect. | GHK | — | 2022-07-01 |
| PRECLINICAL | evidence | Polyaspartic acid, 2-acrylamido-2-Methyl propane sulfonic acid and sodium alginate based biocompatible stimuli responsive polymer gel for controlled release of GHK-Cu peptide for wound healing. | glycyl-L-histidyl-L-lysine copper | — | 2022-07-01 |
| PRECLINICAL | evidence | Skin permeability, a dismissed necessity for anti-wrinkle peptide performance. | GHK | — | 2022-04-01 |
| PRECLINICAL | evidence | Cutaneous Delivery of Cosmeceutical Peptides Enhanced by Picosecond- and Nanosecond-Domain Nd:YAG Lasers with Quick Recovery of the Skin Barrier Function: Comparison with Microsecond-Domain Ablative Lasers. | Copper tripeptide | — | 2022-02-19 |
| PRECLINICAL | evidence | Biologic Therapies for Severe Asthma. | GHK | — | 2022-01-13 |
| PRECLINICAL | evidence | Glycyl-L-histidyl-L-lysine-Cu(2+) attenuates cigarette smoke-induced pulmonary emphysema and inflammation by reducing oxidative stress pathway. | GHK-Cu | — | 2022-01-01 |
| PRECLINICAL | evidence | Glycyl-L-histidyl-L-lysine-Cu(2+) attenuates cigarette smoke-induced pulmonary emphysema and inflammation by reducing oxidative stress pathway. | GHK | — | 2022-01-01 |
| PRECLINICAL | evidence | Intermediate Cu(II)-Thiolate Species in the Reduction of Cu(II)GHK by Glutathione: A Handy Chelate for Biological Cu(II) Reduction. | GHK | — | 2021-12-06 |
| PRECLINICAL | evidence | Ternary Cu(2+) Complexes of Human Serum Albumin and Glycyl-l-histidyl-l-lysine. | Cu-GHK | — | 2021-11-15 |
| PRECLINICAL | evidence | Ternary Cu(2+) Complexes of Human Serum Albumin and Glycyl-l-histidyl-l-lysine. | GHK | — | 2021-11-15 |
| PRECLINICAL | evidence | Efficient Ternary Polymer Solar Cells with Tunable Crystallinity and Phase Separation of Active Layers via Incorporating GHK-Cu. | GHK | — | 2021-10-06 |
| PRECLINICAL | evidence | Efficient Ternary Polymer Solar Cells with Tunable Crystallinity and Phase Separation of Active Layers via Incorporating GHK-Cu. | Gly-His-Lys-Cu | — | 2021-10-06 |
| PRECLINICAL | evidence | Ergothioneine in a peptide: Substitution of histidine with 2-thiohistidine in bioactive peptides. | GHK | — | 2021-10-01 |
| PRECLINICAL | evidence | The central role of IL-33/IL-1RL1 pathway in asthma: From pathogenesis to intervention. | GHK | — | 2021-09-01 |
| PRECLINICAL | evidence | Measurement of Interpeptidic Cu(II) Exchange Rate Constants of Cu(II)-Amyloid-beta Complexes to Small Peptide Motifs by Tryptophan Fluorescence Quenching. | GHK | — | 2021-06-07 |
| PRECLINICAL | evidence | One-Pot Synthesis-Biocompatible Copper-Tripeptide Complex as a Nanocatalytic Medicine to Enhance Chemodynamic Therapy. | Copper tripeptide | preclinical | 2021-04-12 |
| PRECLINICAL | evidence | Coassemble dopamine and GHK tripeptide into fluorescent nanoparticles for pH sensing. | GHK | — | 2021-02-01 |
| PRECLINICAL | evidence | Coassemble dopamine and GHK tripeptide into fluorescent nanoparticles for pH sensing. | GHK-Cu | — | 2021-02-01 |
| PRECLINICAL | evidence | Mass spectral and theoretical investigations of the transient proton-bound dimers on the cleavage processes of the peptide GHK and its analogues. | GHK | — | 2021-01-19 |
| PRECLINICAL | evidence | Enhanced angiogenic effects of RGD, GHK peptides and copper (II) compositions in synthetic cryogel ECM model. | GHK-Cu | — | 2021-01-01 |
| PRECLINICAL | evidence | Protective and Anti-Aging Effects of 5 Cosmeceutical Peptide Mixtures on Hydrogen Peroxide-Induced Premature Senescence in Human Skin Fibroblasts. | GHK | preclinical | 2021-01-01 |
| PRECLINICAL | evidence | Enhanced angiogenic effects of RGD, GHK peptides and copper (II) compositions in synthetic cryogel ECM model. | GHK | Wound healing | 2021-01-01 |
| PRECLINICAL | evidence | The copper(II)-binding tripeptide GHK, a valuable crystallization and phasing tag for macromolecular crystallography. | GHK | — | 2020-12-01 |
| PRECLINICAL | evidence | Ternary Cu(II) Complex with GHK Peptide and Cis-Urocanic Acid as a Potential Physiologically Functional Copper Chelate. | GHK | — | 2020-08-27 |
| PRECLINICAL | evidence | Ternary Cu(II) Complex with GHK Peptide and Cis-Urocanic Acid as a Potential Physiologically Functional Copper Chelate. | GHK-Cu | — | 2020-08-27 |
| PRECLINICAL | evidence | QR678 & QR678 Neo Hair Growth Formulations: A Cellular Toxicity & Animal Efficacy Study. | Copper tripeptide-1 | — | 2020-08-01 |
| PRECLINICAL | evidence | Cerebellar transcranial alternating current stimulation modulates human gait rhythm. | GHK | — | 2020-07-01 |
| PRECLINICAL | evidence | Theoretical study of copper binding to GHK peptide. | Cu-GHK | — | 2020-06-01 |
| PRECLINICAL | evidence | Enhanced biological properties of collagen/chitosan-coated poly(epsilon-caprolactone) scaffold by surface modification with GHK-Cu peptide and 58S bioglass. | GHK | — | 2020-06-01 |
| PRECLINICAL | evidence | Enhanced biological properties of collagen/chitosan-coated poly(epsilon-caprolactone) scaffold by surface modification with GHK-Cu peptide and 58S bioglass. | GHK-Cu | — | 2020-06-01 |
| PRECLINICAL | evidence | Theoretical study of copper binding to GHK peptide. | GHK | — | 2020-06-01 |
| PRECLINICAL | evidence | Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients. | GHK | — | 2020-06-01 |
| PRECLINICAL | evidence | Copper-tripeptides (cuzymes) with peroxidase-mimetic activity. | Copper tripeptide | — | 2020-05-05 |
| PRECLINICAL | evidence | The potential of GHK as an anti-aging peptide. | GHK | — | 2020-03-27 |